Literature DB >> 11074469

Elucidation of the HIV-1 virucidal mechanism of methylene blue photosensitization and the effect on primary isolates.

T Owada1, Y Yamada, H Abe, J Hirayama, H Ikeda, S Sekiguchi, K Ikebuchi.   

Abstract

The antiviral activity for primary isolates of human immunodeficiency virus (HIV) type 1 of a combination of methylene blue and light irradiation was investigated, in comparison with their virucidal effects on laboratory-adapted HIV-1. The antiviral mechanism was evaluated in terms of reverse transcriptase activity and viral RNA in the same viral stock. Despite a marked reduction in RNA (>3.07 Log(10)) and infectivity (6.10 Log(10)) under conditions of 1 microM methylene blue and 5 J/cm(2) irradiation when HIV-1(HTLV-IIIB) as a representative HIV-1 was employed, relatively little degradation of the viral envelope (0.20 Log(10)) and reverse transcriptase activity (1.52 Log(10)) was observed. Because no difference in the reduction of infectivity was found between primary isolates and laboratory-adapted HIV-1 (including HIV-2(ROD)), the antiviral mechanism of methylene blue photosensitization may be similar for all types of HIVs. Methylene blue photosensitization seems to deprive HIVs of infectivity, mainly due to RNA damage, and weak structural and functional damage of viral proteins. Copyright 2000 Wiley-Liss Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11074469

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  2 in total

1.  Methylene blue applied to N95 respirators and medical masks for SARS-CoV-2 decontamination: What is the likelihood of inhaling methylene blue?

Authors:  Thomas S Lendvay; Jinwei Xu; James Chen; Tanner Clark; Yi Cui
Journal:  Am J Infect Control       Date:  2022-08       Impact factor: 4.303

2.  Methylene Blue has a potent antiviral activity against SARS-CoV-2 and H1N1 influenza virus in the absence of UV-activation in vitro.

Authors:  Valeria Cagno; Chiara Medaglia; Erich Cerny; Caroline Tapparel; Andreas Cerny; Thomas Cerny; Arnaud Charles-Antoine Zwygart
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.